Your shopping cart is currently empty

[1,3-Bis(2,6-diisopropylphenyl)imidazolidin-2-ylidene](chloro)silver is a silver-N-heterocyclic carbene (Silver-NHC) complex with potent anticancer activity. It effectively inhibits the proliferation of various cancer cell lines by inducing apoptosis. Distinct from classical pathways, its mechanism is independent of caspase activation. Instead, it triggers the release of mitochondrial Apoptosis-Inducing Factor (AIF), which translocates to the nucleus to cause chromatin condensation and large-scale DNA fragmentation. As a novel organometallic anticancer lead, SIPrAgCl holds significant promise for research aimed at overcoming conventional drug resistance in tumors.
silver](https://cdn.targetmol.com/group3/M00/53/47/CgoaEGmCvNaER1ZvAAAAAJKCzsY129.png)

| Description | [1,3-Bis(2,6-diisopropylphenyl)imidazolidin-2-ylidene](chloro)silver is a silver-N-heterocyclic carbene (Silver-NHC) complex with potent anticancer activity. It effectively inhibits the proliferation of various cancer cell lines by inducing apoptosis. Distinct from classical pathways, its mechanism is independent of caspase activation. Instead, it triggers the release of mitochondrial Apoptosis-Inducing Factor (AIF), which translocates to the nucleus to cause chromatin condensation and large-scale DNA fragmentation. As a novel organometallic anticancer lead, SIPrAgCl holds significant promise for research aimed at overcoming conventional drug resistance in tumors. |
| In vitro | The cytotoxicity of [1,3-Bis(2,6-diisopropylphenyl)imidazolidin-2-ylidene](chloro)silver was evaluated in HCT116 and MCF-7 cell lines using MTT assays. Results demonstrated high anti-proliferative potency, with IC50 values in the low micromolar range. Apoptotic features were analyzed via flow cytometry and immunofluorescence. Results confirmed the loss of mitochondrial transmembrane potential and the translocation of AIF from the mitochondria to the nucleus. The cell death induction remained unaffected by caspase inhibitors, validating a caspase-independent apoptotic mechanism [1]. |
| Molecular Weight | 533.93 |
| Formula | C27H38AgClN2 |
| Cas No. | 873297-20-2 |
| Smiles | Cl[Ag]=C1N(C=2C(=CC=CC2C(C)C)C(C)C)CCN1C=3C(=CC=CC3C(C)C)C(C)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.